256 related articles for article (PubMed ID: 10743979)
1. Antiglaucoma medications: a review of safety and tolerability issues related to their use.
Schuman JS
Clin Ther; 2000 Feb; 22(2):167-208. PubMed ID: 10743979
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the efficacy and safety of alpha2-adrenergic agonists, beta-adrenergic antagonists, and topical carbonic anhydrase inhibitors with prostaglandin analogs.
Tanna AP; Rademaker AW; Stewart WC; Feldman RM
Arch Ophthalmol; 2010 Jul; 128(7):825-33. PubMed ID: 20625041
[TBL] [Abstract][Full Text] [Related]
3. A topical prostaglandin for glaucoma.
Med Lett Drugs Ther; 1996 Nov; 38(987):100-1. PubMed ID: 8914508
[No Abstract] [Full Text] [Related]
4. Side effects of glaucoma medications.
Detry-Morel M
Bull Soc Belge Ophtalmol; 2006; (299):27-40. PubMed ID: 16681086
[TBL] [Abstract][Full Text] [Related]
5. The safety and efficacy of glaucoma medication in the pediatric population.
Coppens G; Stalmans I; Zeyen T; Casteels I
J Pediatr Ophthalmol Strabismus; 2009; 46(1):12-8. PubMed ID: 19213271
[TBL] [Abstract][Full Text] [Related]
6. Short- and long-term safety of glaucoma drugs.
Schuman JS
Expert Opin Drug Saf; 2002 Jul; 1(2):181-94. PubMed ID: 12904152
[TBL] [Abstract][Full Text] [Related]
7. [New medical treatments of glaucoma. New strategies?].
Renard JP; May F; Rigal-Sastourne JC; Maurin JF
J Fr Ophtalmol; 2001 Dec; 24(10):1095-9. PubMed ID: 11913242
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of adverse events in self-reported sulfa-allergic patients using topical carbonic anhydrase inhibitors.
Guedes GB; Karan A; Mayer HR; Shields MB
J Ocul Pharmacol Ther; 2013 Jun; 29(5):456-61. PubMed ID: 23445203
[TBL] [Abstract][Full Text] [Related]
9. Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.
Razeghinejad MR; Sawchyn AK; Katz LJ
Expert Opin Pharmacother; 2010 Apr; 11(6):959-68. PubMed ID: 20307220
[TBL] [Abstract][Full Text] [Related]
10. Adverse effects of antiglaucoma medications.
Bartlett JD
Optom Clin; 1991; 1(1):103-26. PubMed ID: 1686842
[TBL] [Abstract][Full Text] [Related]
11. [New drugs in glaucoma therapy].
Gramer E
Klin Monbl Augenheilkd; 1998 Jul; 213(1):aA10-2. PubMed ID: 9743931
[No Abstract] [Full Text] [Related]
12. Use of fixed-dose combination drugs for the treatment of glaucoma.
Khouri AS; Realini T; Fechtner RD
Drugs Aging; 2007; 24(12):1007-16. PubMed ID: 18020533
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical management of the childhood glaucomas.
Talbot AW; Russell-Eggitt I
Expert Opin Pharmacother; 2000 May; 1(4):697-711. PubMed ID: 11249511
[TBL] [Abstract][Full Text] [Related]
14. [The medical treatment of glaucoma].
Sapir-Pichhadze R; Blumenthal E
Harefuah; 2003 Jan; 142(1):66-9, 76. PubMed ID: 12647493
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacology aspects of glaucoma].
Alm A; Berggren L
Nord Med; 1992; 107(12):306-8, 318. PubMed ID: 1361228
[TBL] [Abstract][Full Text] [Related]
16. Primary drug treatment for glaucoma: beta-blockers versus other medications.
Stamper RL; Wigginton SA; Higginbotham EJ
Surv Ophthalmol; 2002; 47(1):63-73. PubMed ID: 11801272
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological advances in the treatment of glaucoma.
Serle JB
Drugs Aging; 1994 Sep; 5(3):156-70. PubMed ID: 7803944
[TBL] [Abstract][Full Text] [Related]
18. Medical management of angle closure glaucoma.
Hoh ST; Aung T; Chew PT
Semin Ophthalmol; 2002 Jun; 17(2):79-83. PubMed ID: 15513460
[TBL] [Abstract][Full Text] [Related]
19. Topical therapies for glaucoma: what family physicians need to know.
Lewis PR; Phillips TG; Sassani JW
Am Fam Physician; 1999 Apr; 59(7):1871-9, 1882. PubMed ID: 10208706
[TBL] [Abstract][Full Text] [Related]
20. Medical management of glaucoma.
Alward WL
N Engl J Med; 1998 Oct; 339(18):1298-307. PubMed ID: 9791148
[No Abstract] [Full Text] [Related]
[Next] [New Search]
